Repository logo
 

TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst.


Change log

Authors

Hermann, Clemens 
van, Hateren Andy 
Trautwein, Nico 
Neerincx, Andreas 
Duriez, Patrick J 

Abstract

Our understanding of the antigen presentation pathway has recently been enhanced with the identification that the tapasin-related protein TAPBPR is a second MHC I-specific chaperone. We sought to determine whether, like tapasin, TAPBPR can also influence MHC I peptide selection by functioning as a peptide exchange catalyst. We show that TAPBPR can catalyse the dissociation of peptides from peptide-MHC I complexes, enhance the loading of peptide-receptive MHC I molecules, and discriminate between peptides based on affinity in vitro. In cells, the depletion of TAPBPR increased the diversity of peptides presented on MHC I molecules, suggesting that TAPBPR is involved in restricting peptide presentation. Our results suggest TAPBPR binds to MHC I in a peptide-receptive state and, like tapasin, works to enhance peptide optimisation. It is now clear there are two MHC class I specific peptide editors, tapasin and TAPBPR, intimately involved in controlling peptide presentation to the immune system.

Description

Keywords

Journal Title

eLife

Conference Name

Journal ISSN

2050-084X
2050-084X

Volume Title

4

Publisher

eLife
Sponsorship
MRC (G0901682)
Royal Society (1562)
Royal Society (uf100371)
WELLCOME TRUST (104647/Z/14/Z)
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (089821/Z/09/Z)
Wellcome Trust (089563/Z/09/Z)